Golden Throat Holdings $108 million HKSE IPO

27/2/2015
IPO

$ 108 million

27/2/2015


Overview:

  • Golden Throat Holdings, the Chinese owner of the lozenge manufacturer, has launched an IPO on the Hong Kong Stock Exchange (HKSE).
  • The company raised around $108 million from the deal, which saw it sell 25% of its estimated share capital.
  • Slaughter and May acted for the issuer.
  • Freshfields Bruckhaus Deringer advised the sponsor.

Jurisdictions:

United States
China
Hong Kong SAR

Deal type:

IPO

Practice area:

Capital markets : Equity

Industry sector:

Healthcare


Firms:

Party: Credit Suisse (Sponsor)


Party: Golden Throat Holdings Group Co Ltd (Issuer)

Lawyers: Benita Yu, John Moore